119 related articles for article (PubMed ID: 37097692)
21. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
[TBL] [Abstract][Full Text] [Related]
22. Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study.
Van Laethem JL; Demols A; Gay F; Closon MT; Collette M; Polus M; Houbiers G; Gastelblum P; Gelin M; Houtte PV; Closset J
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):974-80. PubMed ID: 12829132
[TBL] [Abstract][Full Text] [Related]
23. Weekly paclitaxel as a radiation sensitizer for locally advanced gastric and pancreatic cancers: the Brown University Oncology Group experience.
Sikov WM; Safran H
Front Biosci; 1997 May; 2():e21-7. PubMed ID: 9206986
[TBL] [Abstract][Full Text] [Related]
24. Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer.
Williams TM; Flecha AR; Keller P; Ram A; Karnak D; Galbán S; Galbán CJ; Ross BD; Lawrence TS; Rehemtulla A; Sebolt-Leopold J
Mol Cancer Ther; 2012 May; 11(5):1193-202. PubMed ID: 22411900
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells.
Miyamoto Y; Hosotani R; Doi R; Wada M; Ida J; Tsuji S; Kawaguchi M; Nakajima S; Kobayashi H; Masui T; Imamura M
Anticancer Res; 2001; 21(4A):2449-56. PubMed ID: 11724306
[TBL] [Abstract][Full Text] [Related]
27. Survivin as a radioresistance factor in pancreatic cancer.
Asanuma K; Moriai R; Yajima T; Yagihashi A; Yamada M; Kobayashi D; Watanabe N
Jpn J Cancer Res; 2000 Nov; 91(11):1204-9. PubMed ID: 11092988
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition.
Urick ME; Chung EJ; Shield WP; Gerber N; White A; Sowers A; Thetford A; Camphausen K; Mitchell J; Citrin DE
Clin Cancer Res; 2011 Aug; 17(15):5038-47. PubMed ID: 21690569
[TBL] [Abstract][Full Text] [Related]
29. C-phycocyanin: a natural product with radiosensitizing property for enhancement of colon cancer radiation therapy efficacy through inhibition of COX-2 expression.
Kefayat A; Ghahremani F; Safavi A; Hajiaghababa A; Moshtaghian J
Sci Rep; 2019 Dec; 9(1):19161. PubMed ID: 31844085
[TBL] [Abstract][Full Text] [Related]
30. Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines.
Iwasa T; Okamoto I; Suzuki M; Nakahara T; Yamanaka K; Hatashita E; Yamada Y; Fukuoka M; Ono K; Nakagawa K
Clin Cancer Res; 2008 Oct; 14(20):6496-504. PubMed ID: 18927289
[TBL] [Abstract][Full Text] [Related]
31. Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis.
Wang F; Tang J; Li P; Si S; Yu H; Yang X; Tao J; Lv Q; Gu M; Yang H; Wang Z
Cell Physiol Biochem; 2018; 45(1):54-66. PubMed ID: 29316551
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.
Inoue T; Anai S; Onishi S; Miyake M; Tanaka N; Hirayama A; Fujimoto K; Hirao Y
BMC Urol; 2013 Jan; 13():1. PubMed ID: 23289871
[TBL] [Abstract][Full Text] [Related]
33. Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
Tsujie M; Nakamori S; Nakahira S; Takeda S; Takahashi Y; Hayashi N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Pancreas; 2006 Aug; 33(2):142-7. PubMed ID: 16868479
[TBL] [Abstract][Full Text] [Related]
34. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer.
Fang Y; Zhao L; Xiao H; Cook KM; Bai Q; Herrick EJ; Chen X; Qin C; Zhu Z; Wakefield MR; Nicholl MB
Med Oncol; 2017 Feb; 34(2):23. PubMed ID: 28058630
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitization of pancreatic cancer cells by metformin through the AMPK pathway.
Fasih A; Elbaz HA; Hüttemann M; Konski AA; Zielske SP
Radiat Res; 2014 Jul; 182(1):50-9. PubMed ID: 24909911
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repair.
Wei D; Parsels LA; Karnak D; Davis MA; Parsels JD; Marsh AC; Zhao L; Maybaum J; Lawrence TS; Sun Y; Morgan MA
Clin Cancer Res; 2013 Aug; 19(16):4422-32. PubMed ID: 23780887
[TBL] [Abstract][Full Text] [Related]
37. Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
Shirai Y; Shiba H; Iwase R; Haruki K; Fujiwara Y; Furukawa K; Uwagawa T; Ohashi T; Yanaga K
Cancer Lett; 2016 Jan; 370(2):177-84. PubMed ID: 26546875
[TBL] [Abstract][Full Text] [Related]
38. The effect of ibrutinib on radiosensitivity in pancreatic cancer cells by targeting EGFR/AKT/mTOR signaling pathway.
Tan B; Huang Y; Zhang B; Lin N
Biomed Pharmacother; 2020 Aug; 128():110133. PubMed ID: 32447207
[TBL] [Abstract][Full Text] [Related]
39. Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette.
Wang W; Wang CY; Dong JH; Chen X; Zhang M; Zhao G
World J Gastroenterol; 2005 Apr; 11(13):2026-31. PubMed ID: 15801000
[TBL] [Abstract][Full Text] [Related]
40. The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2.
Yoon DH; Shin JS; Jin DH; Hong SW; Jung KA; Kim SM; Hong YS; Kim KP; Lee JL; Suh C; Lee JS; Kim TW
Anticancer Res; 2012 May; 32(5):1681-8. PubMed ID: 22593446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
